Please login to the form below

Not currently logged in
Email:
Password:

Bedrock appoints new commercial director

Dr Laura Ciccolini brings experience from the Biopharm Group and Sigma Aldrich

Bedrock Healthcare Communications Dr Laura CiccolinaUK-based medical communications agency Bedrock has appointed Dr Laura Ciccolini to be its new commercial director.

She has over 15 years experience in life sciences and biochemical engineering and previously served as a business development manager for chemical, life science and biotech company Sigma Aldrich.

Her prior roles also include executive director and commercial director at pharma and biotech equipment supplier the Biopharma Group.

In her new senior management position at Bedrock she will be tasked with supporting and driving the agency's growth, working across its insights, med comms and multimedia practices.

Ciccolini will report to CEO David Youds, who said: “I am delighted Laura has joined our team and brings such strong experience.

“Laura will be instrumental in shaping the way we connect with clients and their audiences, as well as providing commercial leadership within the agency to ensure we meet our goals as an organisation.”

21st September 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Human behaviour - Sept 21
All change – how untangling human behaviour can encourage better health
Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
Health literacy in the time of COVID-19
In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
Rare thoughts & outcomes - navigating pathways to better outcomes in rare
...